Skip to main content

Treatment Refractory MAC Lung Disease clinical trials at UCSF

1 research study open to eligible people

Treatment refractory MAC lung disease is a condition where lung infections persist despite treatment. UCSF is examining the effectiveness of Clofazimine delivered through inhalation. The clinical trial checks how well the medicine works and its safety for people with persistent lung infections.

Showing trials for

Our lead scientists for Treatment Refractory MAC Lung Disease research studies include .

Last updated: